In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EuroHeart II

EuroHeart II ended on 28 February 2014. To read the press release click here

EuroHeart II is a 3-year project benefiting from financial support received from the European Commission under the EU Health programme 2008 – 2013. It follows up on EuroHeart I and was developed by the European Heart Network, along with 30 partners including the European Society of Cardiology.

The objective of EuroHeart II is to report on and analyse the current situation with regard to cardiovascular and circulatory diseases in the EU. The project will allow a strategic approach that will also help addressing other non-communicable diseases. The project will provide outputs that can be used to develop Community initiatives to promote cardiovascular health.

The specific objectives of EuroHeart II are:

The expected outcomes are:

  • To allow decision makers to develop CVD prevention policies based on the most up- to-data statistical and economic data, analyses and scientific impact models
  • To empower wider stakeholders groups to assess and address the situation in their countries
  • To help empowering the CVD NGO sector to have a larger impact on health related nutrition and physical activity policy in their countries through conferences and meetings presenting the latest evidence
  • To assist in strengthening the impact of the CVD patient community in the decision making process through sharing of knowledge and experience
  • To contribute to improving the outcome of diabetic patients with CVD through providing information on practice characteristics related to the implementation of the diabetic guideline and changes in health outcomes and comparing countries in Europe where the guideline has been extensively disseminated and those countries where the guideline has been poorly disseminated.

The EuroHeart II project has received co-funding from the European Union in the framework of the Health Programme.
Neither the European Commission nor any person acting in its behalf is liable for any use made of this information.